Platform
Company
Pregnancy
Prenatal aneuploidy screening estimates the chance of certain chromosomal conditions. This is screening, not a diagnosis.
Timing and coverage vary by province and clinical scenario; discuss options with your prenatal care team.
Prenatal aneuploidy screening helps estimate the chance of certain chromosomal conditions (for example, trisomy 21). Options vary by province, gestational age, and clinical factors and may include first trimester screening (bloodwork + ultrasound) and/or non-invasive prenatal testing (NIPT) where applicable. Screening results are probabilities; diagnostic tests (CVS or amniocentesis) are used to confirm.
Depending on the option, you may have a blood test, an ultrasound, or both. Results are reported as a risk estimate. If results are higher-risk, follow-up testing is offered.
Follow these tips to prepare for your screening
Guideline Source: Prenatal care (province-defined coverage and pathways vary)
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider for personalized recommendations.